Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV

Clinical trial NCT04437017 · COMPLETED

Trial details

NCT number: NCT04437017
Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2020-02-03
Primary completion: 2022-05-01
Enrollment: 557

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.